Healthcare / Medical Care FacilitiesThailand
$2.92
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $84.8M · quality 48.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
17/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$692M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-34.8%
↓Gross Margin
13.5%
↓Debt/Equity
1.99
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+5.7%
FCF CAGR
+50.9%
FCF margin
16.1%
FCF / Net income
-0.65x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $754.9M · net income $-188.7M · FCF $121.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $754.9M | $754.9M | $756.0M | $669.6M | $639.8M |
| Net Income | $-188.7M | $-188.7M | $-99.8M | $19.1M | $173.1M |
| EBITDA | $-70.3M | $-70.3M | $14.7M | $113.3M | $257.8M |
| EPS | -0.84 | -0.84 | -0.47 | 0.09 | 0.81 |
| Gross Margin | 13.5% | 13.5% | 18.2% | 35.7% | 52.4% |
| Operating Margin | -16.7% | -16.7% | -6.0% | 15.3% | 34.7% |
| Net Margin | -25.0% | -25.0% | -13.2% | 2.9% | 27.1% |
| Balance Sheet | |||||
| Debt/Equity | 1.99 | 1.99 | 1.72 | 1.60 | 0.21 |
| Current Ratio | 0.40 | 0.40 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $121.8M | $121.8M | $84.8M | $64.6M | $35.5M |
| Returns | |||||
| ROE | -34.8% | -34.8% | -14.6% | 2.5% | 20.9% |
| Valuation | |||||
| P/E | — | — | — | 97.86 | 15.06 |
| EV/EBITDA | — | — | 206.73 | 26.99 | 10.20 |
| P/B | 1.22 | 1.22 | 2.76 | 2.43 | 3.15 |
| Growth & Yield | |||||
| Revenue Growth | -0.1% | -0.1% | 12.9% | 4.7% | — |
| EPS Growth | -78.7% | -78.7% | -622.2% | -88.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-51.6%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.47 → -0.84
Residual
-51.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.